Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Aoki

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Therapeutic Advances in Neurological Disorders|March 7, 2022
Direct to angiography suite approaches for the triage of suspected acute stroke patients: a systematic review and meta-analysisAlex Brehm, Ioannis Tsogkas, Johanna M Ospel, et al.
Journal of Atherosclerosis and Thrombosis|February 24, 2022
Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical TrialMasatoshi Koga, Manabu Inoue, Kaori Miwa, et al.
Stroke|December 10, 2020
Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT SubstudyKazunori Toyoda, Manabu Inoue, Sohei Yoshimura, et al.
Stroke|January 11, 2014
Addition of hyperacute MRI AIDS in patient selection, decreasing the use of endovascular stroke therapyDolora Wisco, Ken Uchino, Maher Saqqur, et al.
Journal of the American Heart Association|July 27, 2019
Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom OnsetJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of the Neurological Sciences|March 31, 2020
Cilostazol uncovers covert atrial fibrillation in non-cardioembolic strokeJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 5, 2020
Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc AnalysisJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
Microbleeds and clinical outcome in acute mild stroke patients treated with antiplatelet therapy: ADS post-hoc analysisJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Stroke|January 26, 2017
YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy)Junya Aoki, Kazumi Kimura, Naomi Morita, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 1, 2023
Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes with Alteplase at 0.6 mg/kg in Clinical Practice: THAWS2 StudySohei Yoshimura, Masatoshi Koga, Takashi Okada, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Therapeutic Advances in Neurological Disorders|March 7, 2022
Direct to angiography suite approaches for the triage of suspected acute stroke patients: a systematic review and meta-analysisAlex Brehm, Ioannis Tsogkas, Johanna M Ospel, et al.
Journal of Atherosclerosis and Thrombosis|February 24, 2022
Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical TrialMasatoshi Koga, Manabu Inoue, Kaori Miwa, et al.
Stroke|December 10, 2020
Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT SubstudyKazunori Toyoda, Manabu Inoue, Sohei Yoshimura, et al.
Stroke|January 11, 2014
Addition of hyperacute MRI AIDS in patient selection, decreasing the use of endovascular stroke therapyDolora Wisco, Ken Uchino, Maher Saqqur, et al.
Journal of the American Heart Association|July 27, 2019
Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom OnsetJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of the Neurological Sciences|March 31, 2020
Cilostazol uncovers covert atrial fibrillation in non-cardioembolic strokeJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 5, 2020
Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc AnalysisJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
Microbleeds and clinical outcome in acute mild stroke patients treated with antiplatelet therapy: ADS post-hoc analysisJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Stroke|January 26, 2017
YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy)Junya Aoki, Kazumi Kimura, Naomi Morita, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 1, 2023
Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes with Alteplase at 0.6 mg/kg in Clinical Practice: THAWS2 StudySohei Yoshimura, Masatoshi Koga, Takashi Okada, et al.
Pageof 18